Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders

被引:18
|
作者
Ghirardi, Laura [1 ]
Chen, Qi [1 ]
Chang, Zheng [1 ]
Kuja-Halkola, Ralf [1 ]
Skoglund, Charlotte [2 ]
Quinn, Patrick D. [3 ]
D'Onofrio, Brian M. [1 ,4 ]
Larsson, Henrik [1 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth, Bloomington, IN 47405 USA
[4] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[5] Orebro Univ, Sch Med Sci, Orebro, Sweden
基金
瑞典研究理事会; 美国国家卫生研究院;
关键词
ADHD medication; injuries; neurodevelopmental disorders; DEFICIT-HYPERACTIVITY DISORDER; ADHD MEDICATION; YOUNG-PEOPLE; METHYLPHENIDATE; METAANALYSIS; ATOMOXETINE; POPULATION; PREVALENCE; SYMPTOMS; REGISTER;
D O I
10.1111/jcpp.13136
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Background Attention-deficit/hyperactivity disorder (ADHD) is often associated with other neurodevelopmental disorders (NDs) and with risky behaviors and adverse health outcomes, including injuries. Treatment with ADHD medication has been associated with reduced risk of injuries. However, it is unknown whether the association is present in individuals with co-occurring NDs. The aim of the present study was to estimate the association between ADHD medication use and unintentional injuries in Sweden in children and adolescents with ADHD, including those with co-occurring NDs. Methods Using a linkage of several national registers via the unique personal identification number, we identified individuals with a diagnosis of ADHD and of other NDs, including autism spectrum disorder, intellectual disability, communication disorders, learning disorders and motor disorders. The primary outcome was unintentional injuries. Secondary outcome was traumatic brain injury (TBI). Individuals were followed from January 1st 2006 or their 5th birthday or the date of the first unintentional injury, whichever came last, to December 31st 2013 or their 18th birthday or death, whichever came first. We compared the rate of injuries during periods on-treatment with the rate of injuries during periods off-treatment within the same individual using stratified Cox regression to calculate hazard ratio (HR) with 95% confidence intervals (CIs). Results For children and adolescents with ADHD (N = 9,421) the rate of any unintentional injuries (HR = 0.85; 95% CI = 0.78-0.92) and TBIs (HR = 0.27; 95% CIs = 0.20-0.38) during medicated periods was lower than during non-medicated periods. Similar results were found among individuals with co-occurring NDs (N = 2,986), for unintentional injuries (HR = 0.88; 95% CI = 0.77-1.01) and for TBIs (HR = 0.27; 95% CI = 0.16-0.44). Conclusions Beneficial effects of ADHD medication may extend beyond reduction of ADHD core symptoms to prevention of unintentional injuries in children and adolescents, including individuals with co-occurring NDs.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 50 条
  • [1] Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents
    Ghirardi, Laura
    Larsson, Henrik
    Chang, Zheng
    Chen, Qi
    Quinn, Patrick D.
    Hur, Kwan
    Gibbons, Robert D.
    D'Onofrio, Brian M.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (08): : 944 - 951
  • [2] Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurring Traits and Disorders
    Du Rietz, Ebba
    Coleman, Jonathan
    Glanville, Kylie
    Choi, Shing Wan
    O'Reilly, Paul F.
    Kuntsi, Jonna
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2018, 3 (07) : 635 - 643
  • [3] Consequences of Co-Occurring Attention-Deficit/Hyperactivity Disorder on Children's Language Impairments
    Redmond, Sean M.
    Ash, Andrea C.
    Hogan, Tiffany P.
    LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS, 2015, 46 (02) : 68 - 80
  • [4] Prescribing Stimulants for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Co-occurring Cannabis Use: Considerations for Managing a Clinical Dilemma
    Dernbach, Matthew Robert
    Gray, Kevin M.
    Borich, Abbey
    Seery, Erin
    Russo, Sarah Brice
    Lewis III, E. Thomas
    Gwynette, McLeod Frampton
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (08): : 842 - 846
  • [5] Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder
    Regnart, Judith
    Truter, Ilse
    Meyer, Anneke
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (03) : 275 - 282
  • [6] Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
    Groenman, Annabeth P.
    Schweren, Lizanne J. S.
    Weeda, Wouter
    Luman, Marjolein
    Noordermeer, Siri D. S.
    Heslenfeld, Dirk J.
    Franke, Barbara
    Faraone, Stephen V.
    Rommelse, Nanda
    Hartman, Catharina A.
    Hoekstra, Pieter J.
    Buitelaar, Jan
    Oosterlaan, Jaap
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2019, 28 (09) : 1213 - 1222
  • [7] Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
    Annabeth P. Groenman
    Lizanne J. S. Schweren
    Wouter Weeda
    Marjolein Luman
    Siri D. S. Noordermeer
    Dirk J. Heslenfeld
    Barbara Franke
    Stephen V. Faraone
    Nanda Rommelse
    Catharina A. Hartman
    Pieter J. Hoekstra
    Jan Buitelaar
    Jaap Oosterlaan
    European Child & Adolescent Psychiatry, 2019, 28 : 1213 - 1222
  • [8] Attention-deficit/hyperactivity disorder and risk for psychiatric and neurodevelopmental disorders in siblings
    Jokiranta-Olkoniemi, Elina
    Cheslack-Postava, Keely
    Joelsson, Petteri
    Suominen, Auli
    Brown, Alan S.
    Sourander, Andre
    PSYCHOLOGICAL MEDICINE, 2019, 49 (01) : 84 - 91
  • [9] Medication for Children with Attention-Deficit Hyperactivity Disorder
    Cary E. Jensen
    Clinical Social Work Journal, 2004, 32 : 197 - 214
  • [10] Medication for children with attention-deficit hyperactivity disorder
    Jensen, CE
    CLINICAL SOCIAL WORK JOURNAL, 2004, 32 (02) : 197 - 214